These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20964849)

  • 21. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
    Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
    Mayxay M; Keomany S; Khanthavong M; Souvannasing P; Stepniewska K; Khomthilath T; Keola S; Pongvongsa T; Phompida S; Ubben D; Valecha N; White NJ; Newton PN
    Am J Trop Med Hyg; 2010 Dec; 83(6):1221-9. PubMed ID: 21118925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours).
    Ayede IA; Falade AG; Sowunmi A; Jansen FH
    Malar J; 2010 Dec; 9():378. PubMed ID: 21194422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
    Mayxay M; Thongpraseuth V; Khanthavong M; Lindegårdh N; Barends M; Keola S; Pongvongsa T; Phompida S; Phetsouvanh R; Stepniewska K; White NJ; Newton PN
    Trop Med Int Health; 2006 Aug; 11(8):1157-65. PubMed ID: 16903879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
    Marquiño W; Huilca M; Calampa C; Falconí E; Cabezas C; Naupay R; Ruebush TK
    Am J Trop Med Hyg; 2003 May; 68(5):608-12. PubMed ID: 12812355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Suntharasamai P; Charoenlarp P; Arnold K; Kyle D; Canfield C; Webster K
    Lancet; 1992 Apr; 339(8797):821-4. PubMed ID: 1347854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
    Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
    Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa.
    Massougbodji A; Kone M; Kinde-Gazard D; Same-Ekobo A; Cambon N; Mueller EA
    Trans R Soc Trop Med Hyg; 2002; 96(6):655-9. PubMed ID: 12625145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border.
    Na-Bangchang K; Ruengweerayut R; Mahamad P; Ruengweerayut K; Chaijaroenkul W
    Malar J; 2010 Oct; 9():273. PubMed ID: 20929590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of mefloquine given as a 3-day artesunate-mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai-Myanmar border.
    Hoglund RM; Ruengweerayut R; Na-Bangchang K
    Malar J; 2018 Sep; 17(1):322. PubMed ID: 30176888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d'Ivoire.
    Assi SB; Aba YT; Yavo JC; Nguessan AF; Tchiekoi NB; San KM; Bissagnéné E; Duparc S; Lameyre V; Tanoh MA
    Malar J; 2017 Jan; 16(1):8. PubMed ID: 28049523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali.
    Sagara I; Diallo A; Kone M; Coulibaly M; Diawara SI; Guindo O; Maiga H; Niambele MB; Sissoko M; Dicko A; Djimde A; Doumbo OK
    Am J Trop Med Hyg; 2008 Nov; 79(5):655-61. PubMed ID: 18981499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic efficacy and effects of artesunate-mefloquine and mefloquine alone on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in southwest Nigeria.
    Sowunmi A; Gbotosho GO; Happi C; Okuboyejo T; Folarin O; Balogun S; Michael O
    Am J Trop Med Hyg; 2009 Dec; 81(6):979-86. PubMed ID: 19996425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
    Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
    PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimising operational use of artesunate-mefloquine: a randomised comparison of four treatment regimens.
    Smithuis F; van der Broek I; Katterman N; Kyaw MK; Brockman A; Lwin S; White NJ
    Trans R Soc Trop Med Hyg; 2004 Mar; 98(3):182-92. PubMed ID: 15024929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised efficacy and safety study of two 3-day artesunate rectal capsule/mefloquine regimens versus artesunate alone for uncomplicated malaria in Ecuadorian children.
    Gomez EA; Jurado MH; Cambon N
    Acta Trop; 2003 Dec; 89(1):47-53. PubMed ID: 14636982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
    von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
    Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon.
    Bouyou-Akotet MK; Ramharter M; Ngoungou EB; Mamfoumbi MM; Mihindou MP; Missinou MA; Kurth F; Bélard S; Agnandji ST; Issifou S; Heidecker JL; Trapp S; Kremsner PG; Kombila M
    Wien Klin Wochenschr; 2010 Mar; 122(5-6):173-8. PubMed ID: 20361381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand.
    Carrara VI; Phyo AP; Nwee P; Soe M; Htoo H; Arunkamomkiri J; Singhasivanon P; Nosten F
    Malar J; 2008 Nov; 7():233. PubMed ID: 18986553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.